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Abstract
 
Recent work has revealed correlations between bacterial or viral infections and atherosclerotic
disease. One particular bacterium, 
 
Chlamydia pneumoniae
 
, has been observed at high frequency
in human atherosclerotic lesions, prompting the hypothesis that infectious agents may be neces-
sary for the initiation or progression of atherosclerosis. To determine if responses to gram-neg-
ative bacteria are necessary for atherogenesis, we first bred atherosclerosis-prone apolipoprotein
(apo) E
 
2
 
/
 
2 
 
(deficient) mice with animals incapable of responding to bacterial lipopolysaccha-
ride. Atherogenesis was unaffected in doubly deficient animals. We further tested the role of in-
fectious agents by creating a colony of germ-free apo E
 
2
 
/
 
2
 
 mice. These animals are free of all
microbial agents (bacterial, viral, and fungal). Atherosclerosis in germ-free animals was not
measurably different from that in animals raised with ambient levels of microbial challenge.
These studies show that infection is not necessary for murine atherosclerosis and that, unlike
peptic ulcer, Koch’s postulates cannot be fulfilled for any infectious agent in atherosclerosis.
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Introduction
 
Several types of studies have suggested that infectious agents
may play a role in atherosclerosis and coronary heart disease
(CHD). Atherosclerosis in chickens is exacerbated by infec-
tion with Marek’s disease virus, a member of the herpes vi-
rus family (1, 2), and numerous studies have suggested an as-
sociation of viral pathogens such as CMV and bacterial
pathogens such as 
 
Helicobacter
 
 and 
 
Chlamydia
 
 with human
atherosclerosis (3–5). Recent data has drawn special atten-
tion to the association between 
 
Chlamydia
 
 
 
pneumonia
 
 and
CHD. Most (6–8) though not all (9, 10) studies have found
that patients with CHD are more likely to carry anti-
 
Chlamydia
 
 antibodies than healthy subjects, and several stud-
ies have demonstrated that 
 
Chlamydia
 
 can be detected
immunohistologically in 
 
.
 
70% of atherosclerotic lesions,
whereas it is virtually undetectable in undiseased arteries (5–
8). 
 
C.
 
 
 
pneuomonia
 
 is a gram-negative bacteria that may pro-
duce persistent infection through intracellular growth in
macrophages (11), a cell type that plays a dominant and nec-
essary role in atherosclerotic lesions (12, 13). These observa-
tions have led to the hypothesis that 
 
Chlamydia
 
 may play a
causal role in atherosclerosis and CHD (14–18). This hy-
pothesis is made plausible by studies on the association of
 
Helicobacter
 
 
 
pylori
 
 and duodenal ulcer (19, 20). This condi-
tion was originally thought to be caused by excess gastric
acid and was treated by reducing or neutralizing acid. It is
now clear that ulcers are most commonly caused by infec-
tion with 
 
H. pylori
 
, and the most effective treatment in-
volves antibiotics. In the same way, atherosclerosis is cur-
rently thought to be caused by excess plasma cholesterol and
is treated by agents that reduce cholesterol levels. If 
 
Chla-
mydia
 
 or any other pathogen causes atherosclerosis, then a
more effective treatment may be an antibiotic or vaccine.
We have sought evidence for a causal role of infectious
agents in atherosclerosis using the murine apolipoprotein
(apo) E
 
2
 
/
 
2
 
 (deficient) model. Because of the deficiency of
apo E, these animals have high levels of plasma cholesterol
and develop atherosclerosis with a reproducible time course
(21–23). In a first experiment, we bred the apo E
 
2
 
/
 
2
 
 with a
strain of mouse that is unable to respond to bacterial LPS,
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but found no alteration in the rate or extent of atherogene-
sis. In a second study, we developed a colony of germ-free
apo E
 
2
 
/
 
2
 
 animals. We observed no effect of gnotobiosis on
the progress of atherosclerosis. We conclude that neither the
response to infectious agents nor the presence of infectious
agents themselves is absolutely necessary for atherogenesis.
 
Materials and Methods
 
Mice with the 
 
lps
 
d
 
 gene crossed onto a C57BL background
(C57BL/10ScN) were the gift of Dr. Steven K. Chapes (Kansas
State University, Manhattan, KS). These mice exhibited minimal
increases in serum levels of TNF-
 
a
 
 and IL-6 in response to intra-
peritoneal injection of 50 
 
m
 
g of LPS, whereas C57BL and apo
E
 
2
 
/
 
2
 
 animals exhibited 
 
.
 
100-fold elevations in both (not
shown). C57BL/10ScN mice were crossed with apo E
 
2
 
/
 
2
 
 mice
on a C57Bl/6 background (Jackson Laboratories). Apo E
 
2
 
/
 
2
 
/
 
lps
 
d
 
animals were identified in the F2 progeny by the presence of
plasma cholesterol levels 
 
.
 
500 mg/dl and the absence of plasma
elevations of TNF-
 
a
 
 90 min after injection of 50 
 
m
 
g LPS.
Germ-free and control apo E
 
2
 
/
 
2
 
 mice were generated and
maintained at Taconic Farms. Sterility was verified by established
procedures (standard operating procedure [SOP] no. G-LB-
300.04).
For all mice in this study, offspring were weaned at 4 wk of age
onto a high-fat Western-type diet containing 21.22% (g/100 g) fat,
17.01% protein, 48.48% carbohydrate, and 0.15% cholesterol
(TD88137; Harlan Teklad) and maintained on the diet for the re-
mainder of the study. Autoclaved food and water were provided
ad libitum. The Institutional Animal Care and Use Committee of
Merck Research Laboratories approved the animal use for exper-
imentation, and all animals were cared for in accordance with the
Guide for the Care and Use of Laboratory Animals (1996, Na-
tional Research Council).
To measure aortic cholesterol and cholesteryl ester, mice were
killed and gently perfused through the left ventricle with cold
PBS with 5 mM EDTA. All branches and any adipose tissue con-
nected to the aorta were removed, and each aorta was carefully
excised from the aortic root to the right renal artery. The aortas
were blotted dry, minced, and extracted with chloroform/metha-
nol (2:1) according to the method used by Folch et al. (24). Total
and free cholesterol in the aortic extracts were determined using
an enzymatic fluorometric assay modified from previously de-
scribed methods (25, 26), and data are expressed on a per aorta
basis. Plasma cholesterol and triglyceride levels were determined
using standard enzymatic kits (Sigma Chemical Co.).
For histology, mouse hearts were perfused in situ with PBS and
removed with 1 mm of proximal aorta attached. The top half of
the heart was embedded in O.C.T. embedding medium (Fisher
Scientific) and prepared for cryosectioning. 6-
 
m
 
m sections were
collected of the aortic root area, defined as having aortic valve
leaflets present, and mounted on 10-well masked slides. Sections
were stained with hematoxylin-phyloxine-saffron for morphol-
ogy. Additional sections were immunolabeled with mAb L3T4
for CD4 or M1/70 for CD11b (PharMingen) using the horserad-
ish peroxidase method with 3-3
 
9
 
-diamino benzadine as substrate.
 
Results
 
The time course of atherosclerogenesis in apo E
 
2
 
/
 
2
 
 mice
was followed by measuring aortic cholesteryl ester (Fig. 1),
a parameter that tracks with histological progression of ath-
erosclerosis (23; data not shown). To determine a role for
gram-negative bacteria such as 
 
Chlamydia
 
, we first used 
 
lps
 
d
 
mice (27), animals with a congenital deficiency in responses
Figure 1. Accumulation of cholesterol ester in the aortas of apo E2/2
and apo E2/2/lpsd mice fed a high-fat diet. Animals were weaned onto a
high-fat diet, and at the indicated times, aortic cholesterol measurements
were performed as described in Materials and Methods. Each data point
represents the average value from 7–10 animals, with error bars indicat-
ing the SE.
Figure 2. Plasma lipid profiles and aortic cholesterol levels of germ-free
(white bars) and control (black bars) apo E2/2 mice. Apo E2/2 mice were
reared germ free or in the presence of ambient pathogens. At 22 or 32 wk
of age, animals were killed, blood was collected for analysis of plasma
cholesterol and triglyceride, and aortas were harvested and extracted for
determination of cholesterol content. (A and B) Comparisons of plasma
cholesterol and triglyceride levels in control and germ free yield nearly
identical values in male (A) and female (B) apo E2/2 mice at both 22 and
32 wk. None of the small differences reached statistical significance, with
the exception of decreased triglyceride levels for the male germ-free ani-
mals at 22 wk (*P , 0.005) and increased triglyceride levels for the female
germ-free animals at 32 wk (**P 5 0.03). (C and D) Comparisons of aor-
tic free cholesterol and cholesteryl ester levels in male (C) and female (D)
apo E2/2 mice at 22 and 32 wk show a trend toward lower levels in the
germ-free animals at both time points, although statistical significance was
achieved only for the cholesteryl ester in germ-free males at 22 wk (*P ,
0.005) and for the germ-free cholesterol in germ-free females at 22 wk
(†P 5 0.05). However, data shown are expressed on a per aorta basis, and
after correction for the decreased body weight of the germ-free mice,
none of the differences attained statistical significance. For each time
point and sex, group size was $10 animals, with the exception of the
32-wk male germ-free mice, which were reduced to 3 by mortality
caused by aggressive behavior. 
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to the principal inflammatory component of these bacteria,
LPS (endotoxin). LPS is known to stimulate expression of
cytokines (TNF, monocyte chemotactic protein 1 [MCP-
1], and others), adhesion molecules (vascular cell adhesion
molecule 1 [VCAM-1], intercellular adhesion molecule 1
[ICAM-1], 
 
b
 
2 integrins), and enzymes (inducible nitric
oxide synthetase [iNOS], matrix metalloproteinase 9
[MMP9]) observed in atherosclerotic lesions (28) and is a
prime candidate to mediate possible proatherogenic effects
of 
 
Chlamydia
 
. 
 
lps
 
d
 
 mice fail to respond to LPS because of a
deficiency in Toll-like receptor 4 (TLR-4 [29, 30]), a trans-
membrane protein with homology to the IL-1 receptor. 
 
lps
 
d
 
animals were crossed with apo E
 
2
 
/
 
2
 
 animals to yield doubly
deficient animals. The inability of these animals to respond
to LPS was verified by measurements of plasma TNF in re-
sponse to LPS challenge, and their deficiency in apo E was
verified by measurements of plasma cholesterol (described
in Materials and Methods). We observed that development
of atherosclerotic lesions in mice fed a high-fat Western-
type diet was not altered by the deletion of TLR-4 (Fig. 1).
Further studies showed that plasma cholesterol was also not
affected by the absence of TLR-4 (data not shown). This
result suggests that responses to gram-negative bacterial
products are not critical for murine atherogenesis.
To more thoroughly ascertain the role of infectious
agents in atherogenesis, we generated a germ-free colony of
apo E
 
2
 
/
 
2
 
 mice. Founder germ-free apo E
 
2
 
/
 
2
 
 pups were de-
livered by Caesarian section and reared by germ-free foster
mothers. The colony resulting from these founders was
maintained germ free: weekly tests showed that no bacteria
could be grown from feces, bedding, or swabs of the isola-
tor. In addition, animals chosen at random showed no anti-
bodies against any of several viral pathogens. The absence of
intestinal bacteria is known to cause enlargement of the
caecum (31), and dramatically enlarged caeca were ob-
served in all of the animals from the colony.
The progress of hyperlipidemia and atherogenesis in
germ-free animals was compared with that of a second set
of animals taken from the germ-free colony and reared with
ambient pathogens. As expected, control apo E
 
2
 
/
 
2
 
 animals
exhibited extremely high levels of plasma cholesterol and
moderately high triglyceride at both 22 and 32 wk of age
(Fig. 2, A and B). Germ-free animals showed an essentially
identical plasma lipid profile, and lipid changes are thus un-
likely to obscure effects of gnotobiosis on atherogenesis.
In both male and female animals, we observed that the
exclusion of infectious agents caused no consistent differ-
ences in the rate or extent of free cholesterol or cholesteryl
ester accumulation in the aorta (Fig. 2, C and D). We did
observe slightly reduced aortic cholesterol ester in the
germ-free animals that attained statistical significance at 22
wk of age. However, these small differences disappeared
upon correction for reduced body weight observed in the
germ-free animals at the 22-wk time point (28 
 
6 
 
0.6 g for
germ-free males vs. 34 
 
6 
 
0.8 g for control males, and 22 
 
6
 
.02 g for germ-free females vs. 24 
 
6 
 
0.6 g for controls; 
 
P 
 
5
 
0.001). The values for aortic cholesteryl ester in germ-free
mice were also similar to those seen in a control colony that
had never been made germ free (values in Fig. 1).
The similarity of atherogenesis in control and germ-free
animals was confirmed by histologic examination of the
aortic root in animals taken at the 22-wk time point. Well-
Figure 3. Histology of aortic
root lesions in germ-free and
control apo E2/2 mice. (A and
B)  Cryosections of the aortic
root area in mice at 22 wk of age
were stained with hematoxylin-
phyloxine-saffron. Lesions in
both types of animal have fi-
brous components (indicated by
yellow staining) and large areas
that are rich in foam cells (indi-
cated by light purple staining).
White rice grain–shaped spaces
indicative of the extracellular
deposition of cholesterol are also
visible in lesions from control
and germ-free mice. The tissue
staining red is surrounding mus-
cle. Bar 5 156 mm. (C and D)
These sections are stained brown
for the T lymphocyte marker
CD4. Arrowheads indicate the
location of T lymphocytes,
present in both control and
germ-free animals. Bar 5 31
mm. Hearts from five mice of
each type for both males and fe-
males were examined histologically, and the sections shown are representative of the results from all of the mice. The same morphology and cellular
composition was observed in both female and male mice. Histology of hearts from two mice of each type at 32 wk of age similarly revealed no differ-
ences between germ-free apo E2/2 and control apo E2/2 mice (not shown). Additionally, staining for the macrophage marker CD11b revealed compa-
rably stained areas in control and germ-free animals (not shown). 
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developed lesions with necrotic cores, large foam cells, and
fibrous caps were observed in both control and germ-free
specimens (Fig. 3, A and B), and neither quantitative nor
qualitative differences could be detected in observations of
either male or female lesions. A difference in aortic size re-
flecting the smaller body size of the germ-free animals (31)
was readily detected histologically. T cells are found in hu-
man and murine atherosclerotic lesions (12, 23), suggesting
activity of the adaptive immune system. We identified T
cells by immunohistochemistry in both control and germ-
free animals (Fig. 3, C and D), indicating that pathogens are
not required to drive the influx of T cells into atheroscle-
rotic lesions.
 
Discussion
 
The observations presented here indicate that infectious
agents, whether bacterial, viral, or fungal, are not necessary
for murine atherogenesis. Infectious agents do not appear
necessary either for initiation or progression of atherosclero-
sis, nor does the presence of infectious agents alter the mor-
phology or cellular composition of the atherosclerotic le-
sions. Finally, the presence of infectious agents does not
appear to alter the pattern of distribution of lesions along the
aorta (not shown). Rather, it appears that the high-circulat-
ing cholesterol levels in the apo E
 
2
 
/
 
2
 
 animals are sufficient
to initiate and drive atherogenesis. We conclude that Koch’s
postulates cannot be fulfilled for any infectious agent in mu-
rine atherosclerosis. Atherosclerosis in apo E
 
2
 
/
 
2
 
 mice
closely resembles that in humans with respect to histology,
progression, and dependence on circulating cholesterol (23),
and we may thus speculate that infectious agents may not be
necessary for the development of human atherosclerosis.
We wish to emphasize that the observations reported
here relate to atherogenesis, not to plaque rupture, throm-
bus formation, or myocardial infarction. It is possible that
infectious agents play an important role in one or more of
these acute processes. Several current studies are seeking to
define a role for bacterial infection in human CHD by
studying endpoints such as myocardial infarction in patients
randomized to placebo or antibiotic therapy of varying du-
ration. The largest of these studies to report results thus far
has failed to demonstrate a decline in cardiovascular events
in the 6 mo after treatment with antibiotic (32). However,
definitive results must await completion of larger, more ex-
tended trials.
Although our results suggest that pathogens do not serve
as etiologic agents for atherosclerosis, they may still have a
role in exacerbating the disease. Recent reports suggest
that inoculation of atherosclerosis-prone mice with high
doses of 
 
Chlamydia
 
 may cause an approximately twofold
increase in the size of atherosclerotic lesions (33, 34). It is
important to note that stresses such as infection provoke a
set of physiological responses that are uniformly pro-
atherogenic (35–37). These include insulin resistance and
hyperglycemia, elevation of plasma triglycerides, elevated
white blood cell counts, elevated acute phase reactants
(e.g., C-reactive protein and fibrinogen), and depression
of high density lipoprotein (HDL) cholesterol levels. It is
thus possible that infection may exacerbate atherosclero-
genesis, and antibiotics may ameliorate atherogenesis not
through the action of an etiologic agent, but through indi-
rect effects on metabolism and known risk factors.
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